Poxel
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
1
Funding Rounds
$20.3m
Money raised
Overview
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
- Websites:
- Headquarters: Lyon
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Poxel has raised a total of $20.3m in funding over 1 rounds.
Key Insights:
- Poxel Series A round: $20.3m
Poxel Series A round
$20.3m
Industries
Poxel is active in the following industries: